Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2561897 | Pharmacological Research | 2015 | 7 Pages |
Abstract
Type 1 diabetes is a T cell-mediated autoimmune disease. Environmental factors play an important role in the initiation of the disease in genetically predisposed individuals. With the improved control of infectious disease, the incidence of autoimmune diseases, particularly type 1 diabetes, has dramatically increased in developed countries. Increasing evidence suggests that gut microbiota are involved in the pathogenesis of type 1 diabetes. Here we focus on recent advances in this field and provide a rationale for novel therapeutic strategies targeting gut microbiota for the prevention of type 1 diabetes.
Graphical abstractFigure optionsDownload full-size imageDownload high-quality image (95 K)Download as PowerPoint slide
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacology
Authors
Changyun Hu, F. Susan Wong, Li Wen,